0001806540-20-000001.txt : 20200317 0001806540-20-000001.hdr.sgml : 20200317 20200317135137 ACCESSION NUMBER: 0001806540-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200317 EFFECTIVENESS DATE: 20200317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lycia Therapeutics, Inc. CENTRAL INDEX KEY: 0001806540 IRS NUMBER: 843860514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363038 FILM NUMBER: 20720402 BUSINESS ADDRESS: STREET 1: 6175 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-224-7766 MAIL ADDRESS: STREET 1: 6175 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001806540 Lycia Therapeutics, Inc. 6175 NANCY RIDGE DRIVE SAN DIEGO CA CALIFORNIA 92121 858-224-7766 DELAWARE None None Corporation true 2019 Jeremy S. Caldwell 6175 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Executive Officer Director Clare Ozawa 6175 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Thomas Woiwode 6175 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Laurent Fischer 6175 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2020-03-03 false true false 1 50390410 25390410 25000000 false 1 0 0 0 false Lycia Therapeutics, Inc. /s/ Jeremy S. Caldwell Jeremy S. Caldwell Chief Executive Officer 2020-03-17